<?xml version='1.0'?>
<!DOCTYPE art SYSTEM 'http://www.biomedcentral.com/xml/article.dtd'>
<art>
   <ui>1744-859X-7-S1-S119</ui>
   <ji>1744-859X</ji>
   <fm>
      <dochead>Poster presentation</dochead>
      <bibl>
         <title>
            <p>Epilepsy presenting panic attacks and hallucinatory experiences as drug side effect: a case report</p>
         </title>
         <aug>
            <au id="A1" ca="yes">
               <snm>Samuimi-Ardestani</snm>
               <fnm>Seyyed Mehdi</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A2">
               <snm>Zahiroddin</snm>
               <fnm>Alireza</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A3">
               <snm>Khodaifar</snm>
               <fnm>Fatemeh</fnm>
               <insr iid="I1"/>
            </au>
            <au id="A4">
               <snm>Kandjani</snm>
               <fnm>Alireza Shafiee</fnm>
               <insr iid="I1"/>
            </au>
         </aug>
         <insg>
            <ins id="I1">
               <p>Department of psychiatry and behavioral sciences, Imam Hosein Hospital, Shaheed Beheshti University, Tehran, Iran</p>
            </ins>
         </insg>
         <source>Annals of General Psychiatry</source>
         <supplement>
            <title>
               <p>International Society on Brain and Behaviour: 3rd International Congress on Brain and Behaviour</p>
            </title>
            <note>Meeting abstracts - A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1744-859X-7-S1-full.pdf">here</a>.</note>
         </supplement>
         <conference>
            <title>
               <p>International Society on Brain and Behaviour: 3rd International Congress on Brain and Behaviour</p>
            </title>
            <location>Thessaloniki, Greece</location>
            <date-range>28 November &#8211; 2 December 2007</date-range>
            <url>http://www.psychiatry.gr</url>
         </conference>
         <issn>1744-859X</issn>
         <pubdate>2008</pubdate>
         <volume>7</volume>
         <issue>Suppl 1</issue>
         <fpage>S119</fpage>
         <url>http://www.annals-general-psychiatry.com/content/7/S1/S119</url>
         <xrefbib>
            <pubid idtype="doi">10.1186/1744-859X-7-S1-S119</pubid>
         </xrefbib>
      </bibl>
      <history>
         <pub>
            <date>
               <day>17</day>
               <month>04</month>
               <year>2008</year>
            </date>
         </pub>
      </history>
      <cpyrt>
         <year>2008</year>
         <collab>Samuimi-Ardestani et al.; licensee BioMed Central Ltd.</collab>
      </cpyrt>
   </fm>
   <bdy>
      <sec>
         <st>
            <p>Background</p>
         </st>
         <p>Panic disorder is characterized by spontaneous, unexpected occurrence of panic attacks with discrete periods of intense fear accompanied by symptoms like as palpitations, pounding heart, sweating, sensations of shortness of breath, feeling dizzy or lightheadedness and fear of losing control or fear of dying <abbrgrp><abbr bid="B1">1</abbr></abbrgrp>.</p>
         <p>Panic attacks could be primary or secondary in origin. Numerous organic underlying causes such as epilepsy may lead to the development of panic attacks. It has bee declared that although there are no exact data, simple partial seizures are associated with a range of psychiatric disorders in which panic attack is one of them. Therefore, to treat properly, simple partial seizure should be noted as differential diagnosis <abbrgrp><abbr bid="B2">2</abbr></abbrgrp>. Panic-like attacks may occur in simple or complex partial seizures along with depersonalization and derealization experiences similar to the conditions in primary panic attacks <abbrgrp><abbr bid="B3">3</abbr></abbrgrp>. Here we report a case of epilepsy whose main disease presentation was panic attacks and experienced unusual side effects during the course of drug therapy.</p>
      </sec>
      <sec>
         <st>
            <p>Materials and methods</p>
         </st>
         <p>A 22- year- old female reported two panic attacks characterized by abrupt shortness of breath, palpitations, feeling of chocking, extreme fear and feeling of going crazy was referred to the psychiatric emergency at Imam Hossein Hospital in Tehran, Iran. Physical and neurological examinations showed no abnormal findings. She took 0.5 mg of clonazepan and 30 mg of Imipramine each day with the diagnosis of panic disorder and was advised to be followed up in a week.</p>
         <p>In the revisit session, the symptoms of the patient had been considerably decreased, but after 2 weeks she returned with exacerbation of panic attacks with fluetuations in consciousness. The patient described the attacks as such: &#8220;suddenly without fear I feel that my surrounding environment has become dream like and I can't hear the voice of people around&#8221;. In addition she had the history of above attacks without fluctuations in consciouness about 5 years ago which had been relieved without any special medication.</p>
         <p>Thus, with the likely diagnosis of seizure, CT scan and EEG were done derealization and depersonalization states to rule out the organic causes. The CT scan report was normal but EEG showed abnormal waves in form of sharp spike waves in back ground of slow epileptic waves in the right temporal lobe.</p>
         <p>Clonazpam and impiramine were discontinued and sodium valproate was prescribed with 600mg doses each day. After a week, panic attacks and derealization state reduced considerably, but later the patient experienced a brief panic condition and the medication was replaced by crabamazepine 1600mg daily by another physican probably with the clinical suspicion of drug inefficacy. Imipramine restarted with the previous dose (i.e. 50 mg daily) as well. Two weeks later, two derealization states occurred and she would hear some people conversing with each other at times which made her very frightened. She was aware of the auditory hallucinations and declare them through full insight and sun real during the interview, although she had got a partial insight to the hallucinations within the illness. Carbmazpine was again replaced by sodium valproate and the hallucinatory experiences relieved soon.</p>
      </sec>
      <sec>
         <st>
            <p>Results</p>
         </st>
         <p>Till now, the patient has been under sodium valproate as well as 9 months treatment duration with impramine. No panic attack or dissociative state has been developed in this time period.</p>
      </sec>
      <sec>
         <st>
            <p>Conclusions</p>
         </st>
         <p>In this case, epilepsy was known as the underlying cause for panic attacks. Al though some authors have noted auras as major diagnostic factor for epilepsy,we did not detect any aura in the reported case. Moreover, carbamazepine. led to the exacerbation of panic attacks and development of psuedopsychotic episodes. Panic attack could be the primary manifestation of a simple convulsion <abbrgrp><abbr bid="B3">3</abbr><abbr bid="B4">4</abbr><abbr bid="B5">5</abbr><abbr bid="B6">6</abbr><abbr bid="B7">7</abbr></abbrgrp>.</p>
         <p>Hallucinatory experiences can be considered as the direct side effect of cabamazepine consumptions <abbrgrp><abbr bid="B8">8</abbr></abbrgrp>. For instance, in a report of case with visual hallucination carbamazepine was noted as the likely cause. Auditory perceptual disturbance due to carbamazpine was also reported <abbrgrp><abbr bid="B9">9</abbr></abbrgrp>.</p>
         <p>Carbamazepine aggravates absence seizure <abbrgrp><abbr bid="B10">10</abbr></abbrgrp> which may account for the recurrence of panic attack after initiation of the drug in this patient. Meanwhile, several cases with panic attacks have been reported in whom the primary diagnosis was temporal lobe epilepsy <abbrgrp><abbr bid="B11">11</abbr></abbrgrp>. We cannot hypothesize about the coocurence of absence and temporal lobe epilepsy in the patient parly because lack of follow- up EEG tracings. Another cause for development of panic attack after prescription of carbamazepine may be related to the simultaneous prescription of imipramine which lowers seizure threshold as a tricyclic agent consequently <abbrgrp><abbr bid="B12">12</abbr></abbrgrp>.</p>
         <p>Individual drug side effects should be considered as likely underlying causes of panic attacks in which further controlled trials would be necessary.</p>
      </sec>
   </bdy>
   <bm>
      <refgrp>
         <bibl id="B1">
            <title>
               <p>Synopsis of Psychiatry</p>
            </title>
            <aug>
               <au>
                  <snm>Kaplan</snm>
                  <fnm/>
               </au>
               <au>
                  <snm>Sadock's</snm>
                  <fnm/>
               </au>
            </aug>
            <publisher>Lippincott Williams &amp; Wilkins</publisher>
            <edition>9th ed</edition>
            <pubdate>2003</pubdate>
            <fpage>599</fpage>
            <lpage>605</lpage>
            <xrefbib>
               <pubid idtype="pmpid" link="fulltext">14502202</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B2">
            <title>
               <p>Neuropsychiatric aspects of Epilepsy</p>
            </title>
            <aug>
               <au>
                  <snm>Mendes</snm>
                  <fnm>Ashla M</fnm>
               </au>
            </aug>
            <source>Kaplan &amp; Sadock's Comprehensive Textbook of psychiatry</source>
            <publisher>Lippincott Williams and Wilkins</publisher>
            <editor>Sadock BJ, Sadock VA</editor>
            <edition>8 th ed</edition>
            <pubdate>2005</pubdate>
            <volume>1</volume>
            <fpage>385</fpage>
         </bibl>
         <bibl id="B3">
            <title>
               <p>Psychiatic complications in patients with epilepsy: a review</p>
            </title>
            <aug>
               <au>
                  <snm>Marsh</snm>
                  <fnm>L</fnm>
               </au>
               <au>
                  <snm>Rao</snm>
                  <fnm>V</fnm>
               </au>
            </aug>
            <source>Epilepsy Re</source>
            <pubdate>2002</pubdate>
            <volume>49</volume>
            <issue>1</issue>
            <fpage>11</fpage>
            <lpage>33</lpage>
            <note>Mar</note>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/S0920-1211(02)00008-6</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B4">
            <title>
               <p>Panic and epilepsy</p>
            </title>
            <aug>
               <au>
                  <snm>Alvarez- Silva</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Alvarez- Rodriguez</snm>
                  <fnm>J</fnm>
               </au>
               <au>
                  <snm>Perez- Echeverria</snm>
                  <fnm>MJ</fnm>
               </au>
               <au>
                  <snm>Alvarez- Silva</snm>
                  <fnm>I</fnm>
               </au>
            </aug>
            <source>J Anxiety Disord</source>
            <pubdate>2006</pubdate>
            <volume>20</volume>
            <issue>3</issue>
            <fpage>353</fpage>
            <lpage>62</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/j.janxdis.2005.03.002</pubid>
                  <pubid idtype="pmpid" link="fulltext">15955658</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B5">
            <title>
               <p>Is there a pathophysiological and therapeutic link between panic disorder and epilepsy?</p>
            </title>
            <aug>
               <au>
                  <snm>Dantendorfer</snm>
                  <fnm>K</fnm>
               </au>
               <au>
                  <snm>Ameringen</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Baischer</snm>
                  <fnm>W</fnm>
               </au>
            </aug>
            <source>Acta Psychiatr. Scand.</source>
            <pubdate>1995</pubdate>
            <volume>91</volume>
            <fpage>430</fpage>
            <lpage>32</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1111/j.1600-0447.1995.tb09804.x</pubid>
                  <pubid idtype="pmpid">7676842</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B6">
            <title>
               <p>Panic attack symptoms in a patient with left temporal lobe epilepsy</p>
            </title>
            <aug>
               <au>
                  <snm>Saegusa</snm>
                  <fnm>S</fnm>
               </au>
               <au>
                  <snm>Takahashi</snm>
                  <fnm>T</fnm>
               </au>
               <au>
                  <snm>Moria</snm>
                  <fnm>J</fnm>
               </au>
            </aug>
            <source>J Int Med Res</source>
            <pubdate>2004</pubdate>
            <volume>332</volume>
            <issue>1</issue>
            <fpage>94</fpage>
            <lpage>6</lpage>
            <note>Jan &#8211; Feb</note>
         </bibl>
         <bibl id="B7">
            <title>
               <p>The spectrum of organic depersonalization: a review plus four new cases</p>
            </title>
            <aug>
               <au>
                  <snm>Lambert</snm>
                  <fnm>MV</fnm>
               </au>
               <au>
                  <snm>Sierra</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Phillips</snm>
                  <fnm>ML</fnm>
               </au>
               <au>
                  <snm>David</snm>
                  <fnm>AS</fnm>
               </au>
            </aug>
            <source>J Neuropsychiatry Clin Neurosci</source>
            <pubdate>2002</pubdate>
            <volume>14</volume>
            <issue>spring</issue>
            <fpage>2</fpage>
         </bibl>
         <bibl id="B8">
            <title>
               <p>Anti epileptic drug induced hallucination in a child</p>
            </title>
            <aug>
               <au>
                  <snm>Benature</snm>
                  <fnm>MG</fnm>
               </au>
               <au>
                  <snm>Sahim</snm>
                  <fnm>M</fnm>
               </au>
               <au>
                  <snm>Davis</snm>
                  <fnm>RG</fnm>
               </au>
            </aug>
            <source>Pediat Neurol</source>
            <pubdate>2000</pubdate>
            <volume>23</volume>
            <issue>5</issue>
            <fpage>439</fpage>
            <lpage>41</lpage>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/S0887-8994(00)00216-2</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B9">
            <title>
               <p>Prescription Drug Information Tegretol. Carbamazepine. html</p>
            </title>
            <url>http://www.accessmednet.com</url>
         </bibl>
         <bibl id="B10">
            <title>
               <p>Antiepileptic drugs &#8211;induced denovo absence seizures</p>
            </title>
            <aug>
               <au>
                  <snm>Yang</snm>
                  <fnm>MT</fnm>
               </au>
               <au>
                  <snm>Lee</snm>
                  <fnm>WT</fnm>
               </au>
               <au>
                  <snm>Chu</snm>
                  <fnm>LW</fnm>
               </au>
               <au>
                  <snm>Shen</snm>
                  <fnm>YZ</fnm>
               </au>
            </aug>
            <source>Brain Dev</source>
            <pubdate>2003</pubdate>
            <volume>25</volume>
            <issue>1</issue>
            <fpage>51</fpage>
            <lpage>6</lpage>
            <note>Jan</note>
            <xrefbib>
               <pubidlist>
                  <pubid idtype="doi">10.1016/s0387-7604(02)00120-1</pubid>
                  <pubid idtype="pmpid" link="fulltext">12536034</pubid>
               </pubidlist>
            </xrefbib>
         </bibl>
         <bibl id="B11">
            <title>
               <p>Hematological monitoring during therapy with Carbamazepine in Children</p>
            </title>
            <aug>
               <au>
                  <snm>Silverstein</snm>
                  <fnm>FS</fnm>
               </au>
               <au>
                  <snm>Boxer</snm>
                  <fnm>L</fnm>
               </au>
               <au>
                  <snm>Johnston</snm>
                  <fnm>MF</fnm>
               </au>
            </aug>
            <source>Ann Neurol</source>
            <pubdate>1983</pubdate>
            <volume>21</volume>
            <fpage>685</fpage>
            <lpage>60</lpage>
            <xrefbib>
               <pubid idtype="doi">10.1002/ana.410130622</pubid>
            </xrefbib>
         </bibl>
         <bibl id="B12">
            <title>
               <p>Tricyclics and Tetracyclics</p>
            </title>
            <aug>
               <au>
                  <snm>Nelson</snm>
                  <fnm>JC</fnm>
               </au>
            </aug>
            <source>Kaplan and Sadock's Comprehensive Textbook of Psychiatry</source>
            <editor>Sadock BJ, Sadock VA</editor>
            <edition>8th ed</edition>
            <volume>2</volume>
         </bibl>
      </refgrp>
   </bm>
</art>
